15.430 articles found

Valproate-induced reversible cognitive decline presenting as dementia and associated clinical features: A literature review.

Alsukhni RA, Johnson J, Nashef L.

Seizure · 2023-07-25

DOI: 10.1016/j.seizure.2023.07.018PMID: 37515866

Personalized Integrated Care Promoting Quality of Life for Older People: Protocol for a Multicenter Randomized Controlled Trial.

Judica E, Tropea P, Bouça-Machado R, Marín M, Calarota E, Cozma L, Badea R, Ahmed M, Brach M, Ferreira JJ, Corbo M.

JMIR Res Protoc · 2023-07-24

DOI: 10.2196/47916PMID: 37486732

Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review.

Huang G, Li R, Bai Q, Alty J.

Health Inf Sci Syst · 2023-07-22

DOI: 10.1007/s13755-023-00231-0PMID: 37489153

Clinical and functional correlates of parkinsonism in a population-based sample of individuals aged 75 + : the Pietà study.

Vale TC, Cardoso FEC, da Silva DJ, Resende EPF, Maia DP, Cunningham MCQ, Guimarães HC, Machado JCB, Teixeira AL, Caramelli P, Barbosa MT.

BMC Neurol · 2023-07-21

DOI: 10.1186/s12883-023-03290-8PMID: 37479964

Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.

Zenuni H, Bovenzi R, Bissacco J, Grillo P, Simonetta C, Mascioli D, Pieri M, Bernardini S, Sancesario GM, Stefani A, Mercuri NB, Schirinzi T.

Neurobiol Aging · 2023-07-20

DOI: 10.1016/j.neurobiolaging.2023.07.011PMID: 37572524

Brain Target Engagement by CNM-Au8 in Parkinson’s Disease and Multiple Sclerosis: Integrated Imaging Results from the REPAIR-PD and REPAIR-MS Phase 2 Clinical Trials

Ren J, III RBD, Rynders A, Evan J, Evan J, Ligozio S, Ho KS, Sguigna PV, Glanzman R, Hotchkin MT, Dewey RB, Greenberg BM.

· 2023-07-19

DOI: 10.21203/rs.3.rs-3168496/v1

Psychosis in Parkinson’s disease: a clinical biomarker of disease stage and prognosis

Pinho M, Martins D, Martins P, Gomes L, Carvalho S.

European psychiatry : the journal of the Association of European Psychiatrists · 2023-07-19

Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders.

Martindale JM, Sarva H, Martino D, Gilbert DL, Ganos C, Pringsheim T, Black K, Malaty IA, all on behalf of the Movement Disorder Society Tic and Tourette Study Group.

PLoS One · 2023-07-19

DOI: 10.1371/journal.pone.0288408PMID: 37467237

A Randomized Clinical Trial to Evaluate a Digital Therapeutic to Enhance Gait Function in Individuals With Parkinson's Disease.

Alberts JL, Kaya RD, Penko AL, Streicher M, Zimmerman EM, Davidson S, Walter BL, Rosenfeldt AB.

Neurorehabil Neural Repair · 2023-07-19

DOI: 10.1177/15459683231184190PMID: 37465959

Clinical effects of Lewy body pathology in cognitively impaired individuals.

Quadalti C, Palmqvist S, Hall S, Rossi M, Mammana A, Janelidze S, Dellavalle S, Mattsson-Carlgren N, Baiardi S, Stomrud E, Hansson O, Parchi P.

Nat Med · 2023-07-18

DOI: 10.1038/s41591-023-02449-7PMID: 37464058

Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease.

Huang P, Zhang P, Du J, Gao C, Liu J, Tan Y, Chen S.

NPJ Parkinsons Dis · 2023-07-17

DOI: 10.1038/s41531-023-00554-5PMID: 37460569

In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.

Price DL, Khan A, Angers R, Cardenas A, Prato MK, Bani M, Bonhaus DW, Citron M, Biere AL.

NPJ Parkinsons Dis · 2023-07-17

DOI: 10.1038/s41531-023-00552-7PMID: 37460603